TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34474715

Group type: EXPERIMENTAL
Intervention: Forced Oscillation Technique (FOT)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Aerosol Provocation System (APS) dosimeter method
Number of subjects: 162
Study: 34694877

Group type: EXPERIMENTAL
Intervention: Dolutegravir plus 2 nucleoside reverse transcriptase inhibitors
Number of subjects: 314

Group type: COMPARATOR
Intervention: Ritonavir-boosted lopinavir
Number of subjects: 314
Study: 34254654

Group type: EXPERIMENTAL
Intervention: Cold application
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Heat application
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study: 34587567

Group type: EXPERIMENTAL
Intervention: Intermittent theta burst stimulation (iTBS) to the cerebellar midline, administered 5 times/week for 2 weeks.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sham stimulation (control group).
Number of subjects: 64
Study: 32405757

Group type: EXPERIMENTAL
Intervention: Nicotine (7 mg/24 h transdermally)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg p.o., body weight-adjusted)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Nicotine plus Propranolol
Number of subjects: 26

Group type: COMPARATOR
Intervention: Double-placebo
Number of subjects: 26

Group type: COMPARATOR
Intervention: Nicotine only
Number of subjects: 26

Group type: COMPARATOR
Intervention: Propranolol only
Number of subjects: 26
Study: 34192885

Group type: EXPERIMENTAL
Intervention: Tolperisone administered orally three-times daily for 14 days
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study: 33518129

Group type: EXPERIMENTAL
Intervention: In ovo injection of organic microminerals (zinc, manganese, and copper)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Diluent only (control group)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 0-hour holding time (HT)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 24-hour holding time (24HT)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Overall body temperature at hatch
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Overall body temperature at 39 days of age
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: General increase in body temperature during the grow out period
Number of subjects: 108
Study: 32347765

Group type: EXPERIMENTAL
Intervention: LPG stoves
Number of subjects: 800

Group type: COMPARATOR
Intervention: Biomass burning cookstoves
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Older adult women
Number of subjects: 800
Study: 35102808

Group type: EXPERIMENTAL
Intervention: Treadmill training (40‐60% heart rate reserve) and self‐management education for 30 minutes, three times a week for 8 weeks
Number of subjects: 119

Group type: COMPARATOR
Intervention: Usual gait training
Number of subjects: 119
Study: 34092026

Group type: COMPARATOR
Intervention: Whiteness without lamp (WHN)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pola office without lamp (PON)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Whiteness with lamp (WHL)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pola office with lamp (POL)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Temperature increase (internal)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Temperature increase (external)
Number of subjects: 40
Study: 32579432

Group type: EXPERIMENTAL
Intervention: 3-month positive psychological intervention
Number of subjects: 155
Study: 33279277

Group type: EXPERIMENTAL
Intervention: ALGINATE
Number of subjects: 113

Group type: COMPARATOR
Intervention: NPWT
Number of subjects: 113
Study: 35301345

Group type: EXPERIMENTAL
Intervention: ITknife nano
Number of subjects: 50

Group type: COMPARATOR
Intervention: DualKnife
Number of subjects: 50
Study: 33855796

Group type: EXPERIMENTAL
Intervention: PROGRESS + educational booklets
Number of subjects: 431

Group type: COMPARATOR
Intervention: Educational booklets
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: PROGRESS users
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: PROGRESS non-users
Number of subjects: 431
Study: 35794522

Group type: EXPERIMENTAL
Intervention: PROMPT speech motor treatment (intensive 3 weeks period, twice-a-day administration)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care (waitlist control group)
Number of subjects: 60
Study: 33769017

Group type: EXPERIMENTAL
Intervention: Surgeon 1 (more than 20 years of experience)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Surgeon 2 and 3 (10 years of experience)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: CUSUM analysis
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Overall complications
Number of subjects: 135
Study: 32379333

Group type: EXPERIMENTAL
Intervention: Intravenous corticosteroids
Number of subjects: 455

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 455
Study: 36229537

Group type: EXPERIMENTAL
Intervention: Low-dose triple combination polypill (telmisartan-20mg/amlodipine-2.5 mg/chlorthalidone-12.5 mg)
Number of subjects: 700

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 700
Study: 34378260

Group type: EXPERIMENTAL
Intervention: 4% Pistacia atlantica ointment, applied topically three times a day for 8 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo ointment, applied topically three times a day for 8 weeks
Number of subjects: 60
Study: 32250250

Group type: EXPERIMENTAL
Intervention: FFR-guided complete revascularisation
Number of subjects: 885

Group type: COMPARATOR
Intervention: IRA-only treatment
Number of subjects: 885
Study: 33618847

Group type: EXPERIMENTAL
Intervention: Cancellous screws
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Sliding hip screw (SHS)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Vitamin D3 4,000 IU
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 91
Study: 33346518

Group type: EXPERIMENTAL
Intervention: 5-7x concentrated PRP
Number of subjects: 20

Group type: COMPARATOR
Intervention: 2-3x concentrated PRP
Number of subjects: 20
Study: 32709430

Group type: EXPERIMENTAL
Intervention: Pranayama breathing exercise group (PBE-G; n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional breathing exercise group (CBE-G; n = 15)
Number of subjects: 30
Study: 32444038

Group type: EXPERIMENTAL
Intervention: Benson's Relaxation Response (BRR) administered twice a day over 5 consecutive days
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 84
Study: 36274582

Group type: EXPERIMENTAL
Intervention: Tape on the thumb (T2)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Tape on the dorsum of the hand (T1)
Number of subjects: 11

Group type: COMPARATOR
Intervention: No tape (NT)
Number of subjects: 11
Study: 32770665

Group type: EXPERIMENTAL
Intervention: Generic immediate‐release tofacitinib tablet (5 mg)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Brand‐named immediate‐release tofacitinib tablet (5 mg)
Number of subjects: 52

Group type: COMPARATOR
Intervention: High-fat food effect
Number of subjects: 52
Study: 35763413

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3256
Study: 32173638

Group type: EXPERIMENTAL
Intervention: sufentanil and dexmedetomidine
Number of subjects: 160

Group type: COMPARATOR
Intervention: sufentanil and normal saline
Number of subjects: 160
Study: 35606022

Group type: EXPERIMENTAL
Intervention: Regular, low-dose, sustained-release morphine
Number of subjects: 22
Study: 34819515

Group type: EXPERIMENTAL
Intervention: ICT combined with conventional physical therapy (ICT-C)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional physical therapy and gait training (CPT-G)
Number of subjects: 20
Study: 35135524

Group type: EXPERIMENTAL
Intervention: Training and service provision for volunteers
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Dementia attitude and knowledge
Number of subjects: 107
Study: 33724600

Group type: EXPERIMENTAL
Intervention: 8-week adaptive working memory training (WMT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: 8-week nonadaptive intervention (active controls)
Number of subjects: 59
Study: 36164102

Group type: EXPERIMENTAL
Intervention: Tafasitamab (12 mg/kg IV on days 1, 8, 15, and 22 of a 28-day cycle for cycles 1-3, then days 1 and 15 for cycles 4-12) plus Lenalidomide (20 mg PO QD, days 1-21/cycle for 12 cycles) and Rituximab (375 mg/m2 IV on days 1, 8, 15, and 22 of cycle 1, then day 1 of cycles 2-5)
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Tafasitamab plus Lenalidomide and Rituximab
Number of subjects: 588

Group type: COMPARATOR
Intervention: Placebo (0.9% saline solution IV) plus Lenalidomide and Rituximab
Number of subjects: 588
Study: 34047672

Group type: EXPERIMENTAL
Intervention: 5 in-person hypnosis contacts
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 3 in-person hypnosis contacts
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 5 phone hypnosis contacts
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 3 phone hypnosis contacts
Number of subjects: 90
Study: 33393645

Group type: EXPERIMENTAL
Intervention: BNP (B-type natriuretic peptide) via intravenous infusion, 2 µg/kg bolus followed by infusion at 0.01, 0.02, and 0.03 µg/kg/min for 1.5 hours
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nebulized salbutamol (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: BNP (B-type natriuretic peptide)
Number of subjects: 40
Study: 33878621

Group type: EXPERIMENTAL
Intervention: Ketamine infusions (6 infusions over 2 weeks)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Machine learning prediction models
Number of subjects: 83
Study: 32957482

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (two atmospheres of 100% oxygen)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sham treatment (simulation of increased pressure in a chamber with normal air)
Number of subjects: 56
Study: 36113061

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided peripheral intravenous catheters (PIVC)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Length of catheter in vein >2.75 cm
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: First stick success
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Depth of vein >1.2 cm
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: PIVC placement in right extremity
Number of subjects: 257
Study: 32102610

Group type: EXPERIMENTAL
Intervention: Motor Imagery Training (MIT) plus conventional rehabilitation therapy (CRT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (only received CRT)
Number of subjects: 34
Study: 34871100

Group type: EXPERIMENTAL
Intervention: Syringe feeding
Number of subjects: 75

Group type: COMPARATOR
Intervention: Paladai feeding
Number of subjects: 75
Study: 32072340

Group type: EXPERIMENTAL
Intervention: Monopolar dissection preferred (MDP)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Blunt dissection preferred (BDP)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 103
Study: 35257498

Group type: EXPERIMENTAL
Intervention: Withdrawal of therapy
Number of subjects: 49
Study: 33287744

Group type: EXPERIMENTAL
Intervention: Clinical examinations for 3 years + whole-body imaging with CT or FDG-PET/CT and laboratory tests including S100B protein and LDH
Number of subjects: 1300

Group type: COMPARATOR
Intervention: Clinical examinations for 3 years
Number of subjects: 1300
Study: 35338036

Group type: EXPERIMENTAL
Intervention: Early lengthening exercises (at day 1 of rehabilitation)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Delayed lengthening exercises (after being able to run at 70% of maximal speed)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Early lengthening group
Number of subjects: 90

Group type: COMPARATOR
Intervention: Reinjury rates within 2 months
Number of subjects: 90

Group type: COMPARATOR
Intervention: Reinjury rates from 2 to 6 months
Number of subjects: 90

Group type: COMPARATOR
Intervention: Reinjury rates from 6 to 12 months
Number of subjects: 90
Study: 33049392

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate nasal spray (27.5 μg) 2 sprays once daily for 1 week, followed by as-needed use for 5 weeks (FF-as-needed)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Fluticasone furoate nasal spray (27.5 μg) 2 sprays once daily for 6 weeks (FF-regular)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Both groups (FF-as-needed and FF-regular)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate nasal spray (FF-as-needed)
Number of subjects: 108
Study: 32889771

Group type: EXPERIMENTAL
Intervention: 10% H2 O2 gel
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 10% H2 O2 + 3% TMP + 0.1% NaF
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 10% H2 O2 + 0.3% TMP + 0.05% NaF
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Fluoridated dentifrice
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 72
Study: 35192640

Group type: EXPERIMENTAL
Intervention: Hybrid Problem-Based Pedagogy (PBP)
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Pure Problem-Based Pedagogy (PBP)
Number of subjects: 660

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Follow-up at 3 months
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Follow-up at 6 months
Number of subjects: 660
Study: 33189909

Group type: EXPERIMENTAL
Intervention: Topical gelatin-thrombin matrix sealant (TGTMS)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (no TGTMS)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Patients with active bleeding requiring TGTMS (I group)
Number of subjects: 103
Study: 35179593

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Care Alone
Number of subjects: 0
Study: 35656688

Group type: EXPERIMENTAL
Intervention: Zirconia crowns
Number of subjects: 102

Group type: COMPARATOR
Intervention: Strip crowns
Number of subjects: 102
Study: 34647858

Group type: EXPERIMENTAL
Intervention: Escitalopram 10 mg
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation Therapy (PMRT)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 34551211

Group type: EXPERIMENTAL
Intervention: VMAT (Volumetric Modulated Arc Therapy)
Number of subjects: 21

Group type: COMPARATOR
Intervention: 3D-CRT (Three-Dimensional Conformal Radiation Therapy)
Number of subjects: 21
Study: 34310904

Group type: EXPERIMENTAL
Intervention: Androgen receptor inhibitors (apalutamide, enzalutamide, or daralutamide)
Number of subjects: 4117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4117
Study: 32503517

Group type: EXPERIMENTAL
Intervention: Low dose yoga (LD), 60 min per week
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Moderate dose yoga (MD), 150 min per week
Number of subjects: 90

Group type: COMPARATOR
Intervention: Stretch-and-tone control group (STC)
Number of subjects: 90
Study: 36411058

Group type: EXPERIMENTAL
Intervention: Bardoxolone methyl
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 157
Study: 33044394

Group type: EXPERIMENTAL
Intervention: EMONO (1-hour administration of equimolar mixture of oxygen and nitrous oxide)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo (medical air)
Number of subjects: 240
Study: 35590386

Group type: EXPERIMENTAL
Intervention: Intravenous tenecteplase 0.25 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care alone (no thrombolysis)
Number of subjects: 0
Study: 33079379

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 563

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 563
Study: 32199541

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT) + Work Therapy (WT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Work Therapy (WT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 48
Study: 36156571

Group type: EXPERIMENTAL
Intervention: Classic Constraint-Induced Movement Therapy (CCIMT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Modified Constraint-Induced Movement Therapy (MCIMT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 40
Study: 33141791

Group type: EXPERIMENTAL
Intervention: Sham Wi‐Fi on
Number of subjects: 83

Group type: COMPARATOR
Intervention: Sham Wi‐Fi off
Number of subjects: 83
Study: 32088365

Group type: EXPERIMENTAL
Intervention: Positive Psychology (PP) intervention, 8-session weekly phone-delivered group format
Number of subjects: 29
Study: 91213894

Group type: EXPERIMENTAL
Intervention: 10 g wheat bran (WB)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 30 g wheat bran (WB)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 10 g mixed vegetable fiber (VF)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 30 g mixed vegetable fiber (VF)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 30 g sugar-beet fiber (SBF)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Fiber-free diet
Number of subjects: 34
Study: 35241345

Group type: EXPERIMENTAL
Intervention: Triheptanoin (0.3–1 g × kg−1 × day−1)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo liquid
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Triheptanoin
Number of subjects: 3
Study: 32044339

Group type: EXPERIMENTAL
Intervention: Motivation manipulation (prompting to focus on positive outcomes of winning)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Neutral condition (control group)
Number of subjects: 98
Study: 34397085

Group type: EXPERIMENTAL
Intervention: Face mask worn by confederate
Number of subjects: 2722
Study: 34184295

Group type: EXPERIMENTAL
Intervention: Melatonin (10 mg orally for 24 weeks)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo (24 weeks)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Melatonin (10 mg orally for 24 weeks) in nondiabetic patients
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo in diabetic patients
Number of subjects: 92
Study: 36285795

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (2000 IU/d)
Number of subjects: 1025

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1025

Group type: EXPERIMENTAL
Intervention: n−3 fatty acids (1 g/d)
Number of subjects: 1025
Study: 32576151

Group type: EXPERIMENTAL
Intervention: Lidocaine by continuous intravenous administration
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 40
Study: 34954348

Group type: EXPERIMENTAL
Intervention: Infrared sauna
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (resting)
Number of subjects: 10
Study: 36198051

Group type: EXPERIMENTAL
Intervention: Equine umbilical cord MSCs
Number of subjects: 80
Study: 33526970

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum-GMNL6
Number of subjects: 0
Study: 32760144

Group type: EXPERIMENTAL
Intervention: Aussie-FIT intervention (12 weekly 90-min sessions)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Aussie-FIT intervention
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 130
Study: 35417878

Group type: EXPERIMENTAL
Intervention: Hydrocortisone phonophoresis (10%) combined with static progressive stretching and home exercise program
Number of subjects: 29

Group type: COMPARATOR
Intervention: Static progressive stretching and home exercise program
Number of subjects: 29
Study: 35436823

Group type: EXPERIMENTAL
Intervention: Early initiation of low-dose hydrocortisone therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 120
Study: 34510642

Group type: COMPARATOR
Intervention: Frail patients compared to robust patients
Number of subjects: 541

Group type: COMPARATOR
Intervention: Prefrail patients compared to robust patients
Number of subjects: 541
Study: 32166624

Group type: EXPERIMENTAL
Intervention: Low-dose amitriptyline (25 mg once daily before bedtime)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine treatment with pantoprazole (40 mg once daily)
Number of subjects: 60
Study: 35810012

Group type: EXPERIMENTAL
Intervention: Nonsurgical periodontal treatment
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study: 33578661

Group type: EXPERIMENTAL
Intervention: Preventive outreach educational intervention (oral health education in two one-hour sessions)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 66
Study: 32091226

Group type: EXPERIMENTAL
Intervention: Clinician-led Body Project
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Peer-led Body Project
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Internet-based eBody Project
Number of subjects: 680

Group type: COMPARATOR
Intervention: Educational video control
Number of subjects: 680
Study: 35247906

Group type: EXPERIMENTAL
Intervention: Famitinib (20 mg orally on days 1-28), Camrelizumab (200 mg intravenously on days 1 and 15), Nab-paclitaxel (100 mg/m2 intravenously on days 1, 8, and 15 in 4-week cycles)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Famitinib, Camrelizumab, and Nab-paclitaxel combination
Number of subjects: 48
Study: 32529630

Group type: EXPERIMENTAL
Intervention: Drug intervention clinical trials (various drugs including molecular target drugs)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Phase 3, randomized, blinded, for-profit-company supported/sponsored, multi-center trials
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Clinical trials of newly developed molecular target drugs (e.g., EGFR-TKIs, ALK inhibitors, immune checkpoint inhibitors)
Number of subjects: 200
Study: 34601588

Group type: EXPERIMENTAL
Intervention: Extended information about the CT examination including visualization of individual coronary calcium score images.
Number of subjects: 92

Group type: COMPARATOR
Intervention: Standard care (no extended information or examination result).
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Extended information about the CT examination.
Number of subjects: 92

Group type: COMPARATOR
Intervention: Standard care.
Number of subjects: 92
Study: 32863075

Group type: EXPERIMENTAL
Intervention: Poster intervention
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 105